Environmental Protection Agency Finalizes Stronger Air Quality Standards
By Physician’s Briefing Staff HealthDay Reporter
FRIDAY, Feb. 9, 2024 -- The U.S. Environmental Protection Agency has introduced a tougher air quality standard that takes aim at fine particulate matter by lowering the allowable annual concentration of the deadly pollutant that each state can have.
"This final air quality standard will save lives and make all people healthier, especially within America's most vulnerable and overburdened communities," EPA Administrator Michael Regan said in an agency news release announcing the change. "Cleaner air means that our children have brighter futures, and people can live more productive and active lives."
The EPA noted that "a broad and growing body of science" links particulate matter to serious, and often deadly, illnesses such as lung cancer, heart disease, kidney disease, neurological disorders, asthma attacks, and stroke.
Reaction to the new standard was enthusiastic. "The Biden administration is taking lifesaving action to protect people and rein in deadly pollution," Abigail Dillen, president of the nonprofit law organization Earthjustice, said in the EPA news release. "The science is crystal clear. Soot, otherwise known as fine particle pollution, is a killer. It is driving heart disease, our asthma epidemic, and other serious illnesses. The people who suffer most are children and older Americans who live in communities of color and low-income communities."
Before the new air quality standard was announced, the allowable annual concentration of particulate matter within a state could not exceed 12 µg/m3. However, the American Lung Association and other health groups have called for that limit to be lowered to 8 µg/m3. The new EPA standard hews more closely to that tougher standard: It sets an annual threshold of 9 µg/m3.
The EPA estimated that the new standard would prevent up to 4,500 premature deaths in the first year the new standard is fully enforced; states will not need to meet the tougher limit until 2032. The agency also noted that the lower limit will yield up to $46 billion in health benefits by lowering the number of lost workdays and reducing emergency room visits.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms
WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.